Similarly, Li et al. found that the median sLAG-3 levels in patients with cervical cancer were significantly lower than that in the healthy controls (3.76 vs. 8.36 ng/mL), and low sLAG-3 level was an independent predictor of cervical cancer [46]. Here, LAG3 is linked to cervical carcinoma.